Silver Sponsor

Allucent, formed from the recent merger of CATO SMS and Pharm-Olam, is a global clinical services organization uniquely positioned to serve small and mid-sized biopharmaceutical companies. With more than 30 years of experience delivering solutions globally, we understand how to develop and implement the right strategy throughout the lifecycle of your product. With 161 infectious disease studies to date, our expertise includes all phases (I-IV) of infectious disease and vaccine clinical development. With an integrated approach encompassing regulatory, clinical, and scientific capabilities, we’re adept at overcoming the challenges routinely appearing in these complex therapeutic areas.